1. Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial. Issue 1 (January 2022) Authors: Costa, Alberto C S; Brandão, Ana C; Boada, Richard; Barrionuevo, Veridiana L; Taylor, Hudson G; Roth, Elizabeth; Stasko, Melissa R; Johnson, Mark W; Assir, Fernanda F; Roberto, Maria P; Salmona, Patrícia; Abreu-Silveira, Guilherme; Bederman, Ilya; Prendergast, Erin; Hüls, Anke; Abrishamcar, Sarin... Journal: Lancet neurology Issue: Volume 21:Issue 1(2022) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗